Ian Smith

Ian Smith has served as a member of our Board of Directors since April 2021. Ian is a biotechnology leader with more than 20 years of finance and operations experience. He is currently the chief executive officer and board member of Stoke Therapeutics. Ian also serves as a senior advisor to Bain Capital Life Sciences, brings considerable governance experience with service on the boards of numerous organizations, and provides consulting services to various biotechnology companies.

Prior to his current roles, he was executive vice president and chief operating officer of Vertex Pharmaceuticals Inc., as well as chief financial officer. Prior to this, Mr. Smith was a partner in the Life Science and Technology Practice of the accounting firm Ernst & Young LLP.

Ian received a B.A. with honors in accounting and finance from Manchester Metropolitan (UK).